Please login to the form below
ESUS
This page shows the latest ESUS news and features for those working in and with pharma, biotech and healthcare.
Xarelto no better than aspirin in secondary stroke study
Patients with ESUS currently have limited treatment options and the role of anticoagulants in this area remains uncertain,” said Joerg Moeller, Bayer's head of development. ... We will now analyse the data from NAVIGATE ESUS to better understand this
Latest news
-
Pradaxa cleared for new indications in Europe
Boehringer also hopes to extend Pradaxa's uses into the prevention of recurrent stroke, and recently started a 6, 000-patient study in embolic stroke of undetermined source (ESUS).
-
Boehringer unveils large study in stroke prevention
Specifically, the 6, 000-patient study will look at the safety and efficacy of Pradaxa (dabigatran) in people who have already suffered an embolic stroke of undetermined source (ESUS), in other ... Boehringer announced the new trial - called RE-SPECT
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
NOAC Education: Empowering Stroke Prevention
Prophylactic anticoagulation is also being explored in conditions such as embolic strokes of undetermined source (ESUS) or when there is a risk of a patient developing venous thromboembolism (VTE).
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
